Pharmadrug Inc. (TSE:PHRX) has released an update.
PharmaDrug Inc. is advancing its patent-pending process for producing pharmaceutical-grade biosynthetic cocaine, targeting the safe supply market. The company is gearing up for commercialization by establishing strategic partnerships and leveraging streamlined regulatory pathways to accelerate market entry. Emphasizing quality and safety, PharmaDrug aims to offer a reliable alternative to street drugs, aligning with harm reduction and rehabilitation initiatives.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.
